8 ms·
I've yet to read an article about Superhuman that doesn't look like it was written by an investor. Was given an invite, which is really just a ticket to purchas
by _zachs 7y ago
I've yet to read an article about Superhuman that doesn't look like it was written by an investor. Was given an invite, which is really just a ticket to purchase this for $30 a month after filling out a questionnaire. Obviously, I didn't go through with it. Not much of an invite if you ask me.
- kristofferR 7y agoI found this: https://www.nytimes.com/2019/06/27/technology/superhuman-email.html https://www.nytimes.com/2019/06/27/technology/superhuman-ema... But you're right, the linked story reads like ad copy.
- 43920 7y agoThe NYT story also kinda sounds like an ad, actually. Like everything else I've read about Superhuman, it claims that it will somehow revolutionize email, but half the features mentioned in the article already exist in Gmail, and the others sound more like small improvements than something actually new.
- spamizbad 7y agoIf you have an email-centric workflow you'll love it. It's a tool more for managers than makers.
- GeorgeTirebiter 7y agoBut you have to be a Cool Kid who has another Cool Kid send you an invite. Why do they use this 'artificial scarcity' approach? I'm now disinclined to use this service, and to replace it with some scripts in emacs. (One should never, ever leave unencrypted email 'in the cloud'.)
- Timothee 7y agoFWIW, Andreessen Horowitz is an investor in Superhuman. :)
- alexandercrohde 7y agoWell then it's kindof a worthless endorsement, isn't it...?
- meowface 7y agoYes. Not sure why this was posted here. a16z of course has plenty of good and HN-relevant content, but this doesn't look like it.
- jmvoodoo 7y agoOne could argue the investment represents a better endorsement than the blog article. Perhaps a redundant endorsement but certainly not worthless.
- alexandercrohde 7y agoThe investment itself is a meaningful business endorsement. However I said this article is a meaningless endorsement (given the major conflict of interest). In fact, the "hype-factor" and unwillingness to describe in simple terms what the product is makes me more skeptical than I was to begin with.
- randylahey 7y agoIt says so in the article: > And that’s why I am excited to announce that Andreessen Horowitz is leading the Series B financing in Superhuman.